- Report
- May 2025
- 120 Pages
Global
From €4177EUR$4,750USD£3,607GBP
- Report
- January 2025
- 144 Pages
Global
From €3649EUR$4,150USD£3,151GBP
- Report
- January 2025
- 156 Pages
Global
From €3649EUR$4,150USD£3,151GBP
- Report
- January 2025
- 154 Pages
Global
From €2550EUR$2,900USD£2,202GBP
- Report
- January 2025
- 152 Pages
Global
From €3649EUR$4,150USD£3,151GBP
- Report
- January 2025
- 144 Pages
Global
From €3649EUR$4,150USD£3,151GBP
- Report
- January 2025
- 151 Pages
Global
From €3649EUR$4,150USD£3,151GBP
- Report
- June 2025
- 400 Pages
Global
From €4352EUR$4,949USD£3,758GBP
- Report
- June 2025
- 150 Pages
Global
From €2373EUR$2,699USD£2,049GBP
- Report
- June 2025
- 150 Pages
Global
From €2373EUR$2,699USD£2,049GBP
- Report
- June 2025
- 150 Pages
Global
From €2373EUR$2,699USD£2,049GBP
- Report
- June 2025
- 150 Pages
Global
From €2373EUR$2,699USD£2,049GBP
- Report
- June 2025
- 150 Pages
Global
From €2373EUR$2,699USD£2,049GBP
- Report
- June 2025
- 150 Pages
Global
From €2373EUR$2,699USD£2,049GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2452EUR$2,789USD£2,118GBP
- Report
- June 2025
- 200 Pages
Global
From €2452EUR$2,789USD£2,118GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2452EUR$2,789USD£2,118GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2452EUR$2,789USD£2,118GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2452EUR$2,789USD£2,118GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2452EUR$2,789USD£2,118GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more